Product logins

Find logins to all Clarivate products below.


Neurovascular Devices | Market Insights | Asia Pacific | 2023

The global COVID-19 pandemic has had a relatively limited impact on the Asia Pacific neurovascular device market in the short term, and the market will see strong growth through 2031, driven by the launch of new devices, increasing adoption of innovative devices backed by favorable clinical data, and rising demand for neurovascular procedures among the growing aging population, particularly due to the urgent and severe nature of the neurovascular disease treatment procedures.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for neurovascular devices in Asia Pacific from 2019 through 2031.

Related Medtech Insights Reports

Report
Cardiac Rhythm Management Devices – Market Insights – Asia Pacific
The Asia Pacific CRM device market will register modest growth over the forecast period. Key growth drivers include the rising adoption of premium-priced technologies such as CRT devices, leadless…
Report
Aortic Repair Devices – Market Insights – Asia Pacific
The Asia Pacific aortic repair device market is projected to experience robust growth during the forecast period, fueled by rising endovascular procedure volumes, ongoing innovation in aortic stent…
Report
Cardiac Rhythm Management Devices | Market Insights | Asia Pacific (Supplemental) | 2025
The Asia Pacific CRM device market will experience modest growth over the forecast period, driven primarily by the increasing volume of ICM procedures and the adoption of premium-priced devices,…
Report
Biosurgical Agents – Market Insights – Asia Pacific
The biosurgical agent market in Asia Pacific will experience modest growth through 2034, driven by rising surgical procedure volumes and expanding use of biosurgical agents across a broader range…
Report
Structural Heart Closure Devices – Market Insights – Asia Pacific
The Asia Pacific structural heart closure device market will grow strongly overall through 2034, supported by rising AF prevalence, increasing physician confidence in structural heart interventions…